Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-1-26
|
pubmed:abstractText |
Morphine and endogenous peptides can alter developmental processes, inducing changes that can endure into adulthood. Morphiceptin binds to mu opiate receptors and to non-opiate sites labeled by Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2), an endogenous brain peptide known to modulate opiate effects. Morphine, morphiceptin, Tyr-MIF-1, morphine + Tyr-MIF-1, and morphiceptin+Tyr-MIF-1 (50 micrograms, s.c.) were given to rats during their first week of life. Animals given morphine alone or in combination with Tyr-MIF-1 had significantly lower body weights for the first 3 weeks of life and delayed eye opening on day 16. Rats given morphine had hypersensitive tail flick responses on day 9 while those given morphine + Tyr-MIF-1 were hypersensitive on days 3, 8, and 9. Locomotor, passive avoidance, and rotorod behaviors were not altered by the neonatal treatments. Transport of [125I]Tyr-MIF-1 out of the brain was tested on day 23 and found to be increased by neonatal morphine, an effect that was significantly potentiated by neonatal Tyr-MIF-1. The results indicate that neonatal administration of peptides and opiates can affect later peptide transport across the blood-brain barrier as well as selected developmental characteristics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Endorphins,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/MSH Release-Inhibiting Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/morphiceptin,
http://linkedlifedata.com/resource/pubmed/chemical/tyrosyl-prolyl-leucyl-glycinamide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0165-3806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7903224-Analgesics,
pubmed-meshheading:7903224-Animals,
pubmed-meshheading:7903224-Animals, Newborn,
pubmed-meshheading:7903224-Behavior, Animal,
pubmed-meshheading:7903224-Blood-Brain Barrier,
pubmed-meshheading:7903224-Body Weight,
pubmed-meshheading:7903224-Endorphins,
pubmed-meshheading:7903224-Eye,
pubmed-meshheading:7903224-Female,
pubmed-meshheading:7903224-Growth,
pubmed-meshheading:7903224-Iodine Radioisotopes,
pubmed-meshheading:7903224-MSH Release-Inhibiting Hormone,
pubmed-meshheading:7903224-Morphine,
pubmed-meshheading:7903224-Nociceptors,
pubmed-meshheading:7903224-Pain Measurement,
pubmed-meshheading:7903224-Pregnancy,
pubmed-meshheading:7903224-Rats
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
|
pubmed:affiliation |
VA Medical Center, Research Service (151), New Orleans, LA 70146.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|